ArticleScientific reports2024

Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulation.

Qixuan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.